Correlation Between Milestone Pharmaceuticals and Vigil Neuroscience
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Vigil Neuroscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Vigil Neuroscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Vigil Neuroscience, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Vigil Neuroscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Vigil Neuroscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Vigil Neuroscience.
Diversification Opportunities for Milestone Pharmaceuticals and Vigil Neuroscience
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Milestone and Vigil is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Vigil Neuroscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vigil Neuroscience and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Vigil Neuroscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vigil Neuroscience has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Vigil Neuroscience go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Vigil Neuroscience
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.63 times more return on investment than Vigil Neuroscience. However, Milestone Pharmaceuticals is 1.58 times less risky than Vigil Neuroscience. It trades about 0.3 of its potential returns per unit of risk. Vigil Neuroscience is currently generating about -0.3 per unit of risk. If you would invest 143.00 in Milestone Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 44.00 from holding Milestone Pharmaceuticals or generate 30.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Vigil Neuroscience
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Vigil Neuroscience |
Milestone Pharmaceuticals and Vigil Neuroscience Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Vigil Neuroscience
The main advantage of trading using opposite Milestone Pharmaceuticals and Vigil Neuroscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Vigil Neuroscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vigil Neuroscience will offset losses from the drop in Vigil Neuroscience's long position.The idea behind Milestone Pharmaceuticals and Vigil Neuroscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Vigil Neuroscience vs. Molecular Partners AG | Vigil Neuroscience vs. Pmv Pharmaceuticals | Vigil Neuroscience vs. Monte Rosa Therapeutics | Vigil Neuroscience vs. Entrada Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |